90144485 - ZEAL & ZEALAND PHARMA

Information

• Trademark
• 90144485

• Source

• Serial Number

  90144485

• Registration Number

  6986947

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services
  • 45 - Legal services

• Filing Date

  August 28, 2020
  5 years ago

• Registration Date

  February 21, 2023
  2 years ago

• Transaction Date

  February 21, 2023
  2 years ago

• Status Date

  February 21, 2023
  2 years ago

• Published for Opposition Date

  October 19, 2021
  4 years ago

• Location Date

  January 13, 2023
  2 years ago

• First Use Anywhere Date

  June 01, 2021
  4 years ago

• First Use In Commerce Date

  June 01, 2021
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  VENGURLEKAR, SAGAR S

• Attorney Docket Number

  066369.0047

  Attorney Name

  Shannon Marie McKeon

  Law Office Assigned Location Code

  M80

• Owners

  • Zealand Pharma A/S

Case File Statements

• GS0411: (Based on Use in Commerce) Publication of articles and scientific text and posters featuring the results of clinical trials for pharmaceutical preparations related to diabetes, obesity and gastrointestinal diseases; providing educational seminars, educational exhibitions, conferences and training courses, all in the field of diabetes, obesity and gastrointestinal diseases; educational seminars, educational exhibitions, conferences and instructional services relating to medical treatments in the field of diabetes, obesity and gastrointestinal diseases; educational services, namely, organizing and conducting educational programs, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity and gastrointestinal diseases
• DM0000: The mark consists of the wording "ZEAL&" with each letter appearing in white, in a blue circle, an overlapped grey circle, an overlapped yellow circle, an overlapped turquoise circle, a red circle, from left to right, with the grey wording "ZEALAND PHARMA" written below.
• GS0051: (Based on 44(e)) Pharmaceutical preparations for the treatment of diabetes, obesity and gastrointestinal diseases; synthetic peptides for pharmaceuticals purposes for the treatment of diabetes, obesity and gastrointestinal diseases; pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans, namely, pharmaceutical preparations for treating endocrine disorders, immunity disorders, nutritional and metabolic diseases, such as diabetes and obesity; pharmaceutical preparations for the treatment and prevention of hypoglycemia; hypoglycemic agents; medical preparations in the nature of a liquid solution for medical purposes for the treatment and prevention of hypoglycemia; pharmaceutical preparations for treating gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; pharmaceutical preparations altering the immune system, such as complement inhibitors; apparatus and instruments containing pharmaceutical preparations, substances and medicines; medical rescue injection pens containing glucagon to treat severe cases of low blood sugar; pre-filled syringes for medical purposes containing insulin or glucagon or analogues of those
• GS0161: (Based on Use in Commerce) printed pharmaceutical information leaflets in the field of diabetes, obesity and gastrointestinal diseases; printed publications, namely, books, magazines, periodicals and manuals, all in the field of diabetes, obesity and gastrointestinal diseases; printed instructional or teaching matter in the field of diabetes, obesity and gastrointestinal diseases; printed instructional and teaching materials about diagnosing and treatment of diabetes, obesity and gastrointestinal diseases; printed guidelines for diagnosing and treatment of diabetes, obesity and gastrointestinal diseases
• PM0001: ZEAL AND ZEALAND PHARMACY; ZEAL AND ZEALAND PHARMACEUTICALS
• CC0000: The color(s) grey, yellow, turquoise, red, white and blue is/are claimed as a feature of the mark.
• GS0351: (Based on 44(e)) Marketing services; customer relationship management; business administrative services for medical referrals; patient relationship management services; business administration of pharmacy and pharmaceutical benefit plans
• GS0451: (Based on 44(e)) Licensing of patent and intellectual property rights arising from medical and pharmaceutical research and development activities; licensing of proprietary intellectual property
• GS0441: (Based on 44(e)) Medical analysis services for the diagnosis and treatment of humans; medical consulting services in the field of diseases, illnesses and ailments in humans; medical services related to the testing and treatment of patients with diabetes or low blood sugar (hypoglycemia); medical services related to testing and treatment of patients with gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; clinical trials; medical consulting services, namely, providing patient adherence programs to patients suffering from diabetes, obesity or gastrointestinal diseases; providing web-based on-line portals that provide a patient adherence program to patients suffering from diabetes, obesity or gastrointestinal diseases; medical information services, namely, providing information relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical advisory services, namely, providing advisory services relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical services in the nature of patient support relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical information and advice in relation to treatment planning, including information and advice provided via the Internet, databases and application software; consultancy services relating to the aforesaid
• GS0101: (Based on Use in Commerce) Medical apparatus and instruments, namely, diabetes management devices, infusion and injection devices, infusion pumps, infusion pump controllers and parts and attachments thereof; medical devices and sensors used to continuously monitor the concentration of glucose in the human body; blood glucose monitors for medical purposes; glucose monitor accessories, namely, transmitters, receivers, and medical sensor insertion devices; wearable medical devices for insulin monitoring; infusion pumps for improvement of glycemic control and auto-injector pens for the treatment of hypoglycemia; medical rescue injection pens for administrating glucagon; parts and accessories for all the aforesaid goods; wearable health devices for insulin monitoring
• D10000: "ZEALAND PHARMA"
• GS0421: (Based on 44(e)) Scientific and technological services, namely, research and design in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid; providing scientific information on diabetes, obesity and gastrointestinal diseases; providing websites featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity and gastrointestinal diseases; computer services, namely, providing a website featuring technology that enables users to obtain data concerning medical analysis and management of diabetes, obesity and gastrointestinal diseases

Case File Event Statements

• 2/21/2023 - 2 years ago

  52 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 2/21/2023 - 2 years ago

  51 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/14/2023 - 2 years ago

  50 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 1/13/2023 - 2 years ago

  49 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 12/17/2022 - 2 years ago

  48 - ASSIGNED TO EXAMINER Type: DOCK

• 11/15/2022 - 3 years ago

  47 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 10/27/2022 - 3 years ago

  46 - USE AMENDMENT FILED Type: IUAF

• 11/15/2022 - 3 years ago

  45 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/27/2022 - 3 years ago

  44 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 6/23/2022 - 3 years ago

  43 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 6/9/2022 - 3 years ago

  42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/7/2022 - 3 years ago

  41 - SOU EXTENSION 1 GRANTED Type: EX1G

• 6/7/2022 - 3 years ago

  40 - SOU EXTENSION 1 FILED Type: EXT1

• 6/7/2022 - 3 years ago

  39 - TEAS EXTENSION RECEIVED Type: EEXT

• 2/4/2022 - 3 years ago

  38 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 12/14/2021 - 3 years ago

  37 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/19/2021 - 4 years ago

  36 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/19/2021 - 4 years ago

  35 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/29/2021 - 4 years ago

  34 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/13/2021 - 4 years ago

  33 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 9/12/2021 - 4 years ago

  32 - ASSIGNED TO LIE Type: ALIE

• 9/11/2021 - 4 years ago

  31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/11/2021 - 4 years ago

  30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/11/2021 - 4 years ago

  29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/11/2021 - 4 years ago

  28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/11/2021 - 4 years ago

  27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/9/2021 - 4 years ago

  26 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 9/7/2021 - 4 years ago

  25 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 8/24/2021 - 4 years ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/24/2021 - 4 years ago

  23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/24/2021 - 4 years ago

  22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/24/2021 - 4 years ago

  21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 8/24/2021 - 4 years ago

  20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/5/2021 - 4 years ago

  19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 8/5/2021 - 4 years ago

  18 - FINAL REFUSAL E-MAILED Type: GNFR

• 8/5/2021 - 4 years ago

  17 - FINAL REFUSAL WRITTEN Type: CNFR

• 8/3/2021 - 4 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/3/2021 - 4 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/3/2021 - 4 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/27/2021 - 4 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/27/2021 - 4 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/27/2021 - 4 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/25/2021 - 4 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/25/2021 - 4 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/25/2021 - 4 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/7/2021 - 4 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/7/2021 - 4 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/7/2021 - 4 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/30/2020 - 4 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/2/2020 - 5 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 10/1/2020 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/1/2020 - 5 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP